---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-005807"
form_type: "8-K"
ticker: "UG"
cik: "0000101295"
company_name: "UNITED GUARDIAN INC"
filed_at: "2021-08-11T23:59:59+00:00"
generated_at: "2026-06-29T14:29:25.030919+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# United-Guardian Q2 sales up 24% YoY; EPS $0.29 vs $0.26

## Summary
- Q2 2021 revenue $3.66M, up 24% from $2.95M in Q2 2020; net income $1.34M ($0.29 per share) vs. $1.19M ($0.26).
- H1 2021 revenue $7.09M (+13% YoY); net income $2.53M ($0.55 per share) vs. $1.98M ($0.43).
- Cosmetic ingredient sales surged 68% YoY in Q2; pharmaceutical sales strong despite ending Medicaid participation.
- President cautions Delta variant may impact cosmetic ingredient sales in H2 but expects pharmaceutical resilience.

## SEC filing metadata
- accession: 0001171843-21-005807
- form_type: 8-K
- ticker: UG
- cik: 0000101295
- company_name: UNITED GUARDIAN INC
- filed_at: 2021-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/101295/000117184321005807/0001171843-21-005807-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/101295/000117184321005807/f8k_080921.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-005807
- JSON: https://secwatch.observer/filing/0001171843-21-005807.json
- Plain text: https://secwatch.observer/filing/0001171843-21-005807.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.